I NTRODUCTION
Inflammatory responses are now believed to play a primary role in immunologic and allergic responses. Eosinophils are considered to be a major type of inflammatory cell, because they cause tissue damage with their granular proteins and also modulate inflammation by producing cytokines. 1 Adhesion molecules participate in an important part of inflammatory process, including eosinophil migration and accumulation into inflamed sites. 2 Among the β 1 integrins, very late antigen (VLA)-4 binds vascular cell adhesion molecule (VCAM)-1 and fibronectin (FN), and the β 2 integrins Mac-1 and LFA-1 bind to intercellular adhesion molecule (ICAM)-1, expressed on eosinophils. These integrins have been considered to play a role in cell activation as well as cell adhesion. Signals via adhesion molecules augment the release of granular proteins, the production of reactive oxygen species (ROS) [3] [4] [5] and eosinophil survival. 6, 7 The expression of adhesion molecules differs depending upon the cells and tissue. For example, VCAM-1 is mainly expressed on the surface of vascular endothelial cells, ICAM-1 is expressed on respiratory epithelium and vascular endothelial cells and FN is expressed in the interstitium. 8 not been studied sufficiently. In the present study, to elucidate these differences, the survival of eosinophils cultured with adhesion molecules was examined by flow cytometry analysis. Moreover, a comparative study on the prolongation of eosinophil survival via adhesion molecules was performed.
M ETHODS

Eosinophil preparation
Peripheral venous blood was obtained from subjects with mild to moderate eosinophilia. Eosinophils were isolated by sedimentation with 6% dextran followed by centrifugation on 1.088 Percoll (Pharmacia, Uppsala, Sweden) density gradients, 9 as modified from the method of Hansel et al . 10 Cells were further purified by negative selection using anti-CD16 immunomagnetic beads and a MACS system (Miltenyi Biotec, Bergisch Gladbach, Germany). Eosinophils (>99% purity) were then suspended in Hank's balanced salt solution (HBSS) with 1% fetal calf serum (FCS) in tubes coated with 3% human serum albumin. Systems, Minneapolis, MN, USA), rs VCAM-1 (R&D Systems), FN (Sigma-Aldrich, St Louis, MO, USA), cellular fibronectin (cFN; Sigma-Aldrich) and connecting segment-1 (CS-1; Sigma-Aldrich) at 37 ° C for 1 h. Blocking was then performed with 1% bovine serum albumin (BSA). Eosinophils were suspended in RPMI 1640 (Nissui Pharmaceutical, Tokyo, Japan) containing 3% FCS at a concentration of 1 × 10 6 /mL for culture in a 5% CO 2 atmosphere at 37 ° C. The plate was coated with 1% BSA as a control.
Eosinophil culture
Assay for eosinophil survival
Eosinophils were washed twice in cold phosphate-buffered saline (PBS) after incubation with or without various concentrations of adhesion molecules (0.1, 1, 10 and 50 µ g/mL) for 18 or 36 h. Then, double staining with propidium iodide (PI) and annexin V (AV) (Apoptosis Detection Kit; MBL, Nagoya, Japan) and FACScan assay (Becton-Dickinson, San Jose, CA, USA) were performed. 11 The percentage of viable cells was given by the percentage of double-negative cells depicted in the lower left quadrant.
Statistical analysis
Results are expressed as the mean ± SEM. An ANOVA was used for group analysis. For Fisher's multiple comparison test, P < 0.05 was considered significant.
R ESULTS
Effects of adhesion molecules on eosinophil survival
Eosinophils were cultured with or without 10 µ g/mL ICAM-1, VCAM-1, FN or cFN for 18 h. The percentage of viable cells was then determined using a flow cytometer, after eosinophils were double stained with AV and PI ( Fig. 1 ). Intercellular adhesion molecule-1 (56.9 ± 8.8%; P < 0.05), FN (63.8 ± 11.2%; P < 0.01) and cFN (64.6 ± 5.3%; P < 0.01), but not VCAM-1 (42.9 ± 2.6%; P > 0.05), significantly prolonged eosinophil survival compared with control (38.6 ± 6.0%; Fig. 2 ). With regard to the number of apoptotic cells, indicated by the percentage of AV-positive and PInegative cells, there were no significant differences among groups cultured with various adhesion molecules (data not shown). The percentage of viable cells after 36 h was also examined, but no significant differences were observed ( Table 1) .
Effect of various concentrations of adhesion molecules on eosinophil survival
To investigate the effect of various concentrations of adhesion molecules on eosinophil survival, eosinophils were cultured with adhesion molecules at concentrations of 0.1, 1, 10 and 50 µ g/mL for 18 h on the basis of results described above (Fig. 3 ). Fibronectin and cFN prolonged eosinophil survival, with the peak effect at concentrations of 10 µ g/mL FN (63.8 ± 11.3%; P < 0.01) and 50 µ g/mL cFN (68.4 ± 4.9%; P < 0.01). Intercellular adhesion molecule-1 showed the highest prolongation of eosinophil survival at 10 µ g/mL (56.9 ± 8.8%; P < 0.05). Regarding the effect of VCAM-1 on prolonged eosinophil survival, no significant differences were observed with any concentration used.
Effect of the CS-1 region on eosinophil survival
To elucidate the effect of the CS-1 region on eosinophil survival, a comparative study between CS-1, FN and cFN was performed using concentrations of 1 µ g/mL ( Fig. 4) . At 1 µ g/mL, CS-1 significantly prolonged eosinophil survival (71.3 ± 5.2%; P < 0.01) compared with control.
D ISCUSSION
In the present study, it was demonstrated that ligands of both β 1 and β 2 integrins prolonged eosinophil survival. We have reported previously that prolonged survival of eosinophils induced by ICAM-1 was completely blocked by anti-granulocyte-macrophage colony stimulating factor (GM-CSF) 6 and FN also prolonged eosinophil survival, which was related to the production of GM-CSF and interleukin (IL)-3. 12 Thus, these reports suggested that GM-CSF and other cytokines may be produced by eosinophils themselves in response to signals by adhesion molecules. Further investigations should clarify whether cytokines may be produced to prolong eosinophil survival.
Furthermore, the present comparative study on eosinophil survival showed the following tendency: cFN = FN > ICAM-1 > VCAM-1. Iintercellular adhesion molecule-1 and VCAM-1 are mainly expressed in vascular endothelium, whereas FN and cFN are expressed in the interstitium. 8 In this regard, this tendency may reflect a pathophysiologic process during activation of eosinophils at the site of inflammation. Moreover, Wu et al . have reported that VCAM-1 robustly adheres to VLA-4 more than FN. 13 In addition to FN, Meerschaert et al. have reported that eosinophil survival is prolonged by VCAM-1. 14 In the present study, FN prolonged eosinophil survival more than VCAM-1. In addition, to confirm this finding, the effect of the CS-1 region, which is the binding site for FN, was investigated. The CS-1 region, as well as FN, prolonged eosinophil survival more than VCAM-1. Taken together, these findings suggest that the mechanism of cell activation, such as the prolongation of eosinophil survival via adhesion molecules, may be different from that of cell adherence.
We reported previously that eosinophils release eosinophil cationic protein (ECP) and eosinophil-derived neurotoxin (EDN) in response to signaling through the adherence to ICAM-1. 4 Reactive oxygen species, as well as eosinophil granule proteins, from eosinophils are considered inflammatory mediators that cause tissue injury at the inflamed site. In this context, we also reported previously the possible involvement of adhesion molecules in ROS production from eosinophils. 15 The present findings suggest that adhesion molecules may promote tissue damage by eosinophil adherence to the inflamed site and prolongation of eosinophil survival. Symptomatic improvement by the preventing migration and/or activation of eosinophils at the site of airway inflammation was achieved in an animal model of asthma after treatment with an anti-ICAM-1 monoclonal antibody (mAb) or anti-VLA-4 mAb. [16] [17] [18] Therefore, the regulation of adhesion molecules, by not only preventing eosinophil adhesion but also activation, such as prolongation of survival, may be a potential target for the treatment of allergic inflammatory disorders.
